Clinical phenotype of individuals with common COPD investigated during the targeted detection programme for alpha1-antitrypsin deficiency in Italy Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007
A whole genome sequencing association study of severe, uncontrolled asthma Source: International Congress 2018 – Multiomics studies in epidemiology: what can they tell us? Year: 2018
Prolidase deficiency diagnosed by whole exome sequencing in a child with pulmonary capillaritis Source: ERJ Open Res, 5 (2) 00205-2018; 10.1183/23120541.00205-2018 Year: 2019
Incidence of alpha-1-antitrypsin (α1-AT) deficiency in patients with COPD in Poland, preliminary report Source: Eur Respir J 2005; 26: Suppl. 49, 440s Year: 2005
Clinical management of patients newly diagnosed with COPD through targeted case finding and routine care: a longitudinal analysis of the TargetCOPD trial Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018
Alpha1-antytripsin deficiency in portuguese COPD patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
Alpha-1-antitrypsin deficiency in Kazakh subjects with COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
Electrophoresis of blood serum: A helpful diagnostic tool for identifying respiratory patients with alpha1-antitrypsin deficiency Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015
Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016
Challenges in interpreting trends in testing for a1 -antitrypsin deficiency in COPD patients from UK primary care Source: Eur Respir J, 52 (6) 1802064; 10.1183/13993003.02064-2018 Year: 2018
Challenges in interpreting trends in testing for a1 -antitrypsin deficiency in COPD patients from UK primary care Source: Eur Respir J, 52 (6) 1801986; 10.1183/13993003.01986-2018 Year: 2018
A COPD patient case study Source: Annual Congress 2012 - NIV - Meeting the Experts: From state-of-the-art to new technologies Year: 2012
Lack of association between increased mitochondrial DNA 4977 deletion and ATP levels of sputum cells from chronic obstructive pulmonary disease patients versus healthy smokers Source: International Congress 2014 – Passive smoking, active smoking and COPD Year: 2014
Whole Exome Sequencing in familial sarcoidosis targets pathways which may help early diagnosis of severe forms of sarcoidosis. Source: Virtual Congress 2020 – Sarcoidosis: from genetics to epidemiology Year: 2020
COPD case finding in UAESource: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education Year: 2013
Results of a case-detection programme for α1-antitrypsin deficiency in COPD patients Source: Eur Respir J 2005; 26: 616-622 Year: 2005
Altered circulating exosomal RNA profiles detected by next-generation sequencing in patients with severe asthma Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016
The importance of the caregivers’ overload in COPD patients with several admission at our hospital. The other side of the story Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care Year: 2016
Quantitative PCR analysis of fungal DNA in European classrooms and association with respiratory health and pulmonary function in children (HESE study) Source: Annual Congress 2010 - Genetics and risk factors for asthma and COPD Year: 2010
Modelling the long-term effects of an active case finding programme for undiagnosed COPD Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016